Home » Topics » Regulatory » Patents

Patents
RSS

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

New antihypertensive/diuretic isolated from natural source

May 10, 1996

Endothelin antagonists reported by Bristol-Myers Squibb

May 10, 1996

Ciba-Geigy reveals renin inhibitors

May 10, 1996

E. Merck continues to investigate angiotensin II blockers

May 10, 1996

Daicel reports neuronal cell protectant

May 10, 1996

Bayer reports K+ channel modulators for CNS disorders

May 10, 1996

5-HT reuptake inhibitors reported by HMR

May 10, 1996

Taisho discloses new series of sigma-receptor ligands

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.